Year: 2023

Patria Reports Third Quarter 2023 Earnings Results

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

GRAND CAYMAN, Cayman Islands, Nov. 07, 2023 (GLOBE NEWSWIRE) — Patria (Nasdaq:PAX) reported today its unaudited results for the third quarter ended September 30, 2023. The full detailed presentation of Patria’s third quarter 2023 results can be accessed on the Shareholders section of Patria’s website at https://ir.patria.com/. Alex Saigh, Patria’s CEO, said: “We are very pleased to have delivered another strong set of results for the quarter, and we continue to drive growth in a market environment where growth does not come easy. Our Distributable Earnings for 3Q23 were 23 cents per share, driven by Fee Related Earnings of $36 million which is up 14% from the same quarter last year. Organic inflows were $1.3 billion in the third quarter, and including commitments secured in early Q4, our year-to-date organic inflows total...

Science 37 Reports Third Quarter 2023 Financial Results

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter ended September 30, 2023. “Our third quarter results were highlighted by continued quarterly improvements in our key profitability metrics and cash burn rate,” stated David Coman, Chief Executive Officer of Science 37. “We look forward to a strong finish to the year and positive momentum headed into 2024.” Quarterly Financial HighlightsGross bookings were $17.9 million for the quarter ended September 30, 2023, a 50.6% increase compared to $11.9 million for the same period in 2022, and a 53.2% decrease compared to $38.2 million for the second quarter of 2023. Backlog was $163.1 million for the quarter ended September 30,...

ACM Research Reports Third Quarter 2023 Results

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) — ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its third quarter ended September 30, 2023. “We delivered another solid quarter. Revenue grew 26% and shipments were a record $213 million, up 31%,” said ACM’s President and Chief Executive Officer, Dr. David Wang. “Our results demonstrate spending on mature nodes and market share gains at our customer base, together with more contribution from new products and new customers.” Dr. Wang continued, “I am pleased with continued customer demand and execution by the ACM team as we continue on our mission to become a key supplier to major semiconductor manufacturers. We are encouraged by sustained...

Blockchain Intelligence Group Expands Its Global Reach With Spanish Language Integration In Its Cryptocurrency Investigation And Compliance Suite

Written by Customer Service on November 7, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group, and TerraZero is pleased to announce the addition of the Spanish language to its offerings of cryptocurrency investigations and compliance services. This strategic move comes in response to the proliferating demand for cryptocurrency solutions in Spanish-speaking countries. It is a pivotal step to acknowledging the vast business potential in these markets. Crypto Adoption in Spanish-Speaking Countries Spanish-speaking countries have witnessed a remarkable surge in cryptocurrency adoption in recent years. In El Salvador, Bitcoin became a legal tender in 2021, and the government...

Interim report of Copenhagen Airports A-S (CPH) for the period 1 January – 30 September 2023

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

The Board of Directors has today approved the interim report for the period 1 January – 30 September 2023.COPENHAGEN AIRPORTS A/S P.O. Box 74 Lufthavnsboulevarden 6 DK-2770 KastrupContact: Rasmus Lund CFOTelephone: +45 3231 3231 E-mail: cphpresse@cph.dk www.cph.dk CVR nr. 14 70 72 04AttachmentQ3 2023 Report of Copenhagen Airports A-S

Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Press release – No. 15 / 2023 Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023 Copenhagen, Denmark, November 7, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that it will participate in a fireside chat at the Jefferies London Healthcare Conference:Jefferies London Healthcare ConferenceTuesday, November 14 at 1:30 p.m. GMT (2:30 p.m. CET)Fireside chat with Adam Steensberg, President and Chief Executive Officer A webcast of the fireside chat will be available on the Events page in the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/. A replay of the webcast will be archived on the company’s website following the fireside...

Sosei Heptares’ President & CEO and Head of UK R&D to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2023

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Tokyo, Japan and Cambridge, UK, 7 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) announces its President & CEO, Chris Cargill, and Matt Barnes, Head of UK R&D, will participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference on Tuesday, 14 November at 10:30 a.m. GMT / 5:30 a.m. ET / 7:30 p.m. JST. During the event, Mr. Cargill and Dr. Barnes will present the Company’s strategy, recent progress and expected upcoming milestones to leading global life sciences investors. The live webcast of the ‘Fireside Chat’ will be available here. The replay will also be available at the same link or our website (here) for 90 days post the event. -ENDS- About Sosei HeptaresSosei Heptares is a fully integrated biopharmaceutical company focused on bringing life-changing medicines based...

NewHydrogen CEO Steve Hill Discusses Fuel Cell and Battery Electric Vehicles with Former California EPA Official

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Dr. Alan Lloyd maintains that California’s regulations were instrumental in shaping the development of fuel cell technology. SANTA CLARITA, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) — NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of a breakthrough technology that uses clean energy and water to produce the world’s cheapest green hydrogen, today announced that in a recent podcast the Company’s CEO Steve Hill spoke with Dr. Alan Lloyd, former Secretary for the California EPA. During the conversation, Dr. Lloyd explained that California’s initiative to require zero-emission vehicles started in the early 90s to tackle public health issues caused by car and truck emissions. Initially, automakers were resistant to this mandate, but over time, advancements in battery technology and fuel cell vehicles allowed them to meet the...

IDEX Biometrics issues a Convertible Bond to prepare for commercial ramp-up

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Oslo, Norway – 7 November 2023 – IDEX Biometrics (Idex or the Company) has entered into a non-binding term sheet with a new institutional investor group to issue a senior convertible bond for up to 100 million NOK. The convertible bond structure is subject to approval of the formal agreements and shareholder approval. The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Idex may choose repayment between equity and cash for each instalment. Interest rate is 6% pa. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment. To...

Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Leiden, The Netherlands, November 7, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces 14 poster presentations by the Company or its collaborators regarding leniolisib and RUCONEST® at the International Primary Immunodeficiencies Congress (IPIC) and the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in November. IPIC, Rotterdam, The Netherlands, November 8 – 10, 2023Approaches to family testing for autosomal dominant inborn errors of immunity in Europe: results of a blinded survey; Poster #204: Thursday, November 9, 08:00–08:30 CET Results of a second interim analysis of an ongoing single-arm open-label extension study of leniolisib in activated PI3K delta syndrome: long-term efficacy and safety through to March 2023; Poster #214:...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals